SEC Form 4 · accession 0001127602-18-022667
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin E Lofton
Director
Period of report
Jul 1, 2018
Accepted (ET)
Jul 3, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF1,F2 | $0.00 | Jul 1, 2018 | A | 1,623 | A | — | — | Common Stock | 1,623 | 23,156 | D |
Explanation of responses
- F1Each share of phantom stock is the economic equivalent of one share of Gilead common stock.
- F2The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.